• Federal Workers Compensation
  • FELA, Railroad Workers Helpline
  • Jones Act, Harbor Workers Act, Injured Seaman Helpline
  • Mesothelioma Lawyers, Mesothelioma Exposure Helpline
  •  On The Job Accidents and  Injuries, Workers Compensation Lawyers
  • Qui Tam Lawyers, Whistleblower Attorneys
  • What You Need To Know About Workers Compensation
  •  A Workers Compensation Lawyer Can Help You

Mesothelioma Drug to Help Workers

Written by lisaspitzer. Posted in Stories and Sharing

CanBas Developing Mesothelioma Drug to Enhance Chemotherapy Treatment, Help for mesothelioma

Friday, Jan 13, 2012

CanBas Co., Ltd.,, a Japanese bio-pharmaceutical company that develops new cancer drugs that target the cell cycle, has received a boost from the U.S. Food and Drug Administration in its research efforts to add to the arsenal of drugs available to fight malignant mesothelioma.

Mesothelioma is an aggressive cancer of the lining of the lung and abdomen that affects about 3,000 people in the U.S. each year. The mortality rate for mesothelioma is high, so more effective treatment options are needed to stop the progression of the disease.

The company’s lead product is a drug known as CBP501 that enhances the effectiveness of the chemotherapy drug Cisplatin, which is standard treatment for malignant pleural mesothelioma. CBP501, a synthetic peptide, enhances the toxicity of Cisplatin as it accumulates in mesothelioma tumors.

CanBas announced in January that the US FDA has granted orphan drug status to CBP501 for the treatment of malignant mesothelioma. The designation qualifies the pharmaceutical company for financial incentives for the development of drugs used to treat rare diseases. Without such incentives, drug companies have difficulty justifying the investment of time and resources necessary to bring to market drugs used to treat rare diseases that may have only a limited demand and therefore limited profit.

Currently, a randomized clinical trial is underway comparing the results of patients with advanced malignant pleural mesothelioma in the U.S., Russia and Argentina treated with the chemotherapy drugs Cisplatin/pemetrexed with and without the addition of CBP501.

Malignant mesothelioma symptoms usually don’t appear until decades after exposure to asbestos, typically 20 years to 50 years. Because mesothelioma is aggressive, doctors often do not diagnose a patient’s mesothelioma until the disease is well advanced.

For the Injured worker Workers Compensation lawyers for victims of Mesothelioma are here to help you if you have asbestos related cancer.  Our mesothelioma lawyers can help you if you have lost a loved one due to mesothelioma

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Trackback from your site.

Leave a comment

You must be logged in to post a comment.